Renee Browning - Concepedia

Author

Renee Browning

National Institute of Allergy and Infectious Diseases

Also Known As

Charl Botha, Karin Klingman, N. Chakhtoura, Piper, Jeanna, R Browning, R. Browning, Renee Browning, Renee S Browning, Renee S. Browning, Vivian Rexroad

Publications

1.8K

Citations

H-Index

Concepts

All Affiliations

National Institute of Allergy and Infectious Diseases Eunice Kennedy Shriver National Institute of Child Health and Human Development Cancer Research And Biostatistics National Institutes of Health Stellenbosch University

About

Renee Browning is an author at National Institute of Allergy and Infectious Diseases specializing in medicine, pediatrics, and tuberculosis prevention.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	10	10	1.1K
2	Public Health	5	5	250
3	Engineering	2	2	62
4	Health Sciences	1	1	32
5	Biostatistics	1	1	32

Renee Browning

Publications

1.6K

Citations

H-Index

Page 1

	Year	Citations
Benefits and Risks of Antiretroviral Therapy for Perinatal HIV Prevention Mary Glenn Fowler, Min Qin, Susan A. Fiscus, New England Journal of Medicine	2016	330
Clinical Case Definitions for Classification of Intrathoracic Tuberculosis in Children: An Update Stephen M. Graham, Luís E. Cuevas, Patrick Jean‐Philippe, Clinical Infectious Diseases Tuberculosis PreventionDiagnosisCase SeriesConsensus Case DefinitionsClinical Case Definitions	2015	327
Evaluation of Tuberculosis Diagnostics in Children: 1. Proposed Clinical Case Definitions for Classification of Intrathoracic Tuberculosis Disease. Consensus From an Expert Panel Stephen M. Graham, Tahmeed Ahmed, Farhana Amanullah, The Journal of Infectious Diseases Pulmonary TuberculosisExpert PanelTuberculosis PreventionClinical EpidemiologyDiagnosis	2012	324
Efficacy and safety of dolutegravir with emtricitabine and tenofovir alafenamide fumarate or tenofovir disoproxil fumarate, and efavirenz, emtricitabine, and tenofovir disoproxil fumarate HIV antiretroviral therapy regimens started in pregnancy (IMPAACT 2010/VESTED): a multicentre, open-label, randomised, controlled, phase 3 trial Shahin Lockman, Sean S. Brummel, Lauren Ziemba, The Lancet Treatment And PreventionAntiviral Drug DevelopmentAntiviral TherapyGynecologyMaternal Health	2021	152
Evaluation of Tuberculosis Diagnostics in Children: 2. Methodological Issues for Conducting and Reporting Research Evaluations of Tuberculosis Diagnostics for Intrathoracic Tuberculosis in Children. Consensus From an Expert Panela Luís E. Cuevas, Renee Browning, Patrick Bossuyt, The Journal of Infectious Diseases Tuberculosis PreventionDiagnosisPediatric Lung DiseaseDiagnosticsMedical Diagnosis	2012	113
Toward Earlier Inclusion of Pregnant and Postpartum Women in Tuberculosis Drug Trials: Consensus Statements From an International Expert Panel Amita Gupta, Jyoti S. Mathad, Susan M. Abdel‐Rahman, Clinical Infectious Diseases Tuberculosis PreventionReproductive HealthGynecologyInternational Expert PanelTuberculosis Drugs	2015	62
Early Initiation of Lopinavir/Ritonavir in Infants Less Than 6 Weeks of Age Ellen G. Chadwick, Jorge Pinto, Ram Yogev, The Pediatric Infectious Disease Journal	2009	54
Pregnancy Outcomes of Women Conceiving on Antiretroviral Therapy (ART) Compared to Those Commenced on ART During Pregnancy Gerhard Theron, Sean S. Brummel, Lee Fairlie, Clinical Infectious Diseases	2020	34
Pharmacokinetics and Drug‐Drug Interactions of Isoniazid and Efavirenz in Pregnant Women Living With HIV in High TB Incidence Settings: Importance of Genotyping Kamunkhwala Gausi, Lubbe Wiesner, Jennifer Norman, Clinical Pharmacology & Therapeutics PharmacotherapyAntiviral DrugHigh-risk PregnancyMolecular PharmacologyEfavirenz Exposures	2020	34
Lung boundary detection in pediatric chest x-rays Sema Candemir, Sameer Antani, Stefan Jaeger, Proceedings of SPIE, the International Society for Optical Engineering/Proceedings of SPIE Boundary Detection AlgorithmWorld Health OrganizationEngineeringDiagnosisDiagnostic Imaging	2015	32

Page 1